| |
| |
|
| Insider
Information: |
Lieu Hsiao |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
12,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,795 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
12,600 |
|
|
| Total
Value |
$3,795 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -57.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Capricor Therapeutics |
CAPR |
Executive VP, Clinical... |
2012-03-30 |
12,600 |
2012-03-30 |
0 |
Premium* |
|
|
Ngm Biopharmaceuticals Inc |
NGM |
|
2024-04-05 |
0 |
2020-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGM |
Ngm Biopharmaceuticals In... |
Chief Medical Officer |
• – – |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,349) |
0 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
EVP, CHIEF MEDICAL OFFICER |
• – – |
2024-01-16 |
4 |
D |
$1.34 |
$7,276 |
D/D |
(5,430) |
54,254 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
53,000 |
55,605 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-10-05 |
4 |
AS |
$22.00 |
$44,000 |
D/D |
(2,000) |
0 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-10-05 |
4 |
OE |
$12.06 |
$24,120 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-08-12 |
4 |
S |
$23.50 |
$188,000 |
D/D |
(8,000) |
0 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-08-12 |
4 |
OE |
$12.06 |
$96,480 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2021-08-11 |
4 |
S |
$23.00 |
$51,934 |
D/D |
(2,258) |
0 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2020-05-15 |
4 |
S |
$22.00 |
$34,364 |
D/D |
(1,562) |
182 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
SVP, Chief Medical OfficerOffi |
• – – |
2020-03-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,562 |
|
- |
|
| CAPR |
Capricor Therapeutics |
Executive VP, Clinical Dev. |
• – – |
2012-03-30 |
4 |
B |
$0.00 |
$0 |
D/D |
12,500 |
12,600 |
2.66 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
